Loading...
Sonidegib, a novel smoothened inhibitor for the treatment of advanced basal cell carcinoma
Basal cell carcinoma (BCC) is the most common nonmelanoma skin cancer. If left untreated, BCCs can become locally aggressive or even metastasize. Currently available treatments include local destruction, surgery, and radiation. Systemic options for advanced disease are limited. The Hedgehog (Hh) pat...
Saved in:
| Published in: | Onco Targets Ther |
|---|---|
| Main Authors: | , , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
Dove Medical Press
2016
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5028081/ https://ncbi.nlm.nih.gov/pubmed/27695345 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OTT.S108171 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|